Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 10:12 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 625–648 of 2,819 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: matched control group Clear all

Conditions: Pediatric Obesity
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 10 Years to 18 Years
Enrollment: 295 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Mild Traumatic Brain Injury (mTBI), Post-traumatic Stress Disorder
Interventions: TES; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 60 Years
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: San Diego, California

Conditions: Refractory Hypertension
Interventions: Placebo, TC-5214; Drug
Lead sponsor: Targacept Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Asthma, Allergic
Interventions: REGN3500, Dupilumab, Placebo, Fluticasone propionate; Drug
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Cypress, California

Conditions: Diabetic Nephropathies
Interventions: Placebo matching BI 685509, BI 685509; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years and older
Enrollment: 243 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 17
States / cities: Victorville, California • Waterbury, Connecticut • Hialeah, Florida + 13 more

Conditions: Intestinal Permeability, Gastrointestinal Function
Interventions: Cranberry Beverage, Control Beverage; Other
Lead sponsor: University of Florida; Other
Eligibility: 21 Years to 50 Years
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Chronic Pain
Interventions: Pain relief skills training, Health Education; Behavioral · Other
Lead sponsor: Washington State University; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Spokane, Washington

Conditions: Sensation Disorders, Sensation, Phantom, Pain, Postoperative, Pain, Chronic, Numbness, Sensory Disorder, Sensory Defect, Phantom Pain, Phantom Sensation
Interventions: Sensory testing; Diagnostic Test
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2033
U.S. locations: 2
States / cities: Boston, Massachusetts • New York, New York

Conditions: Chronic Pancreatitis, Inflammatory Bowel Diseases, Hepatitis, NASH - Nonalcoholic Steatohepatitis, Acute Pancreatitis, Rheumatoid Arthritis, Diabetes Mellitus, Dyslipidemias, Multiple Sclerosis, Irritable Bowel Syndrome, Chronic Pain, Chronic Disease, Chronic Kidney Diseases, Crohn Disease, Celiac Disease, Biliary Cirrhosis, Bile Acid Synthesis Defect, Gastritis, Cholecystitis, Cholelithiases, IPMN, Cyst Pancreas, Cystic Fibrosis, Pancreatic Exocrine Insufficiency, Diarrhea Chronic, Constipation - Functional, Constipation Chronic Idiopathic
Interventions: venipuncture, Questionnaires, Additional Sample Collections; Other · Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 12 Years and older
Enrollment: 120,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2026
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Infections, Bacterial
Interventions: Gepotidacin; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 3
States / cities: Miami, Florida • Orlando, Florida • Minneapolis, Minnesota

Conditions: Atopic Dermatitis
Interventions: ENV-294, Placebo; Drug · Other
Lead sponsor: Enveda Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 9
States / cities: Encinitas, California • Los Angeles, California • Northridge, California + 6 more

Conditions: Multiple Sclerosis, Immune System Diseases
Interventions: ocrelizumab; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Narcolepsy
Interventions: ADX-N05, Placebo; Drug
Lead sponsor: Jazz Pharmaceuticals; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 93 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 28
States / cities: Birmingham, Alabama • Phoenix, Arizona • Redwood City, California + 23 more

Conditions: Childhood Obesity, Cardiovascular Disease
Interventions: flavonoid-rich freeze-dried strawberry powder, macronutrient-matched control powder; Dietary Supplement
Lead sponsor: University of California, Davis; Other
Eligibility: 14 Years to 18 Years · Male only
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Davis, California

Conditions: Covid19, Echocardiography, Ultrasound
Interventions: Point of care ultrasound including echocardiography, lung ultrasound, vascular ultrasound; Diagnostic Test
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years and older
Enrollment: 98 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Postpartum Depression
Interventions: Placebo, SAGE-547 60 μg/kg/h, SAGE-547 90 μg/kg/h; Drug
Lead sponsor: Supernus Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 138 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 32
States / cities: Chandler, Arizona • Rogers, Arkansas • Lemon Grove, California + 27 more

Conditions: COVID-19
Interventions: Bamlanivimab; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 12 Years and older
Enrollment: 109 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Generalized Anxiety Disorder
Interventions: Strength Training, Endurance Training; Other
Lead sponsor: University of Georgia; Other
Eligibility: 18 Years to 39 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Athens, Georgia

Conditions: Chronic Kidney Disease
Interventions: Sodium bicarbonate, Controlled diet; Drug · Other
Lead sponsor: Duke University; Other
Eligibility: 22 Years and older
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Renal Transplant Rejection
Interventions: Sirolimus, Demographic Data, Medical History, and Donor Data, Blood Draws for Control Group, Blood Draws for Experimental Group, Donor Blood Draws, Donor Information, Kidney Biopsy; Drug · Other · Procedure
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 275 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Major Depression
Interventions: Band Together, Control Mobile 3D video game; Behavioral · Other
Lead sponsor: University of Washington; Other
Eligibility: 45 Years to 75 Years
Enrollment: 79 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 2
States / cities: White Plains, New York • Seattle, Washington

Conditions: Non Alcoholic Steatohepatitis (NASH)
Interventions: Icosabutate, Placebo; Drug
Lead sponsor: NorthSea Therapeutics B.V.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 280 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 38
States / cities: Birmingham, Alabama • Chandler, Arizona • Glendale, Arizona + 31 more

Conditions: Chronic Pain, Mild Cognitive Impairment
Interventions: Feeling of Being, Health Enhancement Program; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 50 Years to 120 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Fetal Alcohol Spectrum Disorders, Fetal Alcohol Syndrome, Fetal Alcohol Effect
Interventions: General information, Baseline brief intervention, Remote online booster sessions, SMS; Other · Behavioral
Lead sponsor: Michigan State University; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 384 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Flint, Michigan

Search by objective public record fields.

Pediatric Obesity Observational Prospective Trial

Transcranial Electrical Stimulation for mTBI

TC-5214 as Augmentation Therapy in Patients With Refractory Hypertension

Study of REGN3500 and Dupilumab in Patients With Asthma

A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Diabetic Kidney Disease

The Effect of a Cranberry Beverage on Intestinal Permeability and Gastrointestinal Function in Generally Healthy Adults

Nurse-Delivered Brief Pain Relief Skills Treatment in Rural Communities

Prospective Study of Sensation and Satisfaction in Cancer and Transgender Mastectomy Patients

Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study

Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal Function

A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Mechanism of Action of Ocrelizumab in Multiple Sclerosis

A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy

The Effects of California Strawberries on Parameters of Cardiovascular Health

Evaluate Long Term Cardiovascular and Pulmonary Complications After COVID-19 With Point of Care Ultrasound

A Study to Evaluate Efficacy and Safety of SAGE-547 in Participants With Severe Postpartum Depression (547-PPD-202B)

A Real World Study of Bamlanivimab in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

Exercise Training for the Treatment of Generalized Anxiety Disorder

Acid-Base Compensation in Chronic Kidney Disease

Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients

ESTIA: Computerized Intervention Targeting Cognitive Control Deficits in Depressed Adults

A Phase 2b Study of Icosabutate in Fatty Liver Disease

Mindfulness-Based Cognitive Therapy Vs. the Health Enhancement Program for Chronic Pain and Early Cognitive Decline; The Feeling of Being Pilot RCT

Scaling Up: A Multi-Site Trial of e-SBI for Alcohol Use in Pregnancy